Devices › Gynecological laparoscopic kit
Device brand name · Gynecologic laparoscope and accessories
Upsylon Y Mesh Kit: medical device reports filed with FDA
248 reports name it, 2014–2022. Manufacturer given most often on reports: Boston Scientific. Product code OHD.
- 248
- device reports naming the brand
- 0% of all MAUDE reports · about 20 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 2.8%
- classified as malfunction
- 26.8% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
248 medical device reports received by FDA name the brand "Upsylon Y Mesh Kit" (gynecologic laparoscope and accessories); the manufacturer given most often on reports is Boston Scientific; received from March 2014 to October 2022. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (97.2%) and malfunction (2.8%); across all gynecological laparoscopic kit reports (product code OHD) death is recorded in 0% and malfunction in 26.8%. Event type is the reporter's classification of the report, not a verified outcome.
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 366 reports carrying product code OHD. Event type is the filer's classification and is not verified by FDA.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Painpain, site not specified | 184 | 74.2% |
| Incontinence | 143 | 57.7% |
| Constipationconstipation | 133 | 53.6% |
| Dyspareunia | 123 | 49.6% |
| Abnormal vaginal discharge | 49 | 19.8% |
| Erosion | 37 | 14.9% |
| Prolapse | 8 | 3.2% |
| Urinary tract infectionbladder or urinary infection | 7 | 2.8% |
| Micturition urgency | 4 | 1.6% |
| Depressionlow mood | 3 | 1.2% |
| Injurya physical injury | 3 | 1.2% |
| Cramp(s) /muscle spasm(s) | 2 | 0.8% |
| Hemorrhage/blood loss/bleeding | 2 | 0.8% |
| Bacterial infectiona bacterial infection | 1 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Upsylon Y Mesh Kit | Product code OHD | All MAUDE reports |
|---|---|---|---|
| Reports | 248 | 366 | 26,136,888 |
| Share of that pool | — | 67.8% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 97.2% | 73.2% | 36.2% |
| Classified as malfunction | 2.8% | 26.8% | 62.3% |
| Filed by the manufacturer | 99.6% | 88.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code OHD
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Mesh | 267 | 2 | 0.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Upsylon Y Mesh Kit reports
How many FDA reports name Upsylon Y Mesh Kit?
248 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (97.2%) and malfunction (2.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
No device problem codes are listed.
Who files these reports?
manufacturer reports (99.6%) and voluntary reports (0.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Upsylon Y Mesh Kit was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.